Jerome C. Bressi

679 total citations
10 papers, 582 citations indexed

About

Jerome C. Bressi is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jerome C. Bressi has authored 10 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Jerome C. Bressi's work include Biochemical and Molecular Research (6 papers), Trypanosoma species research and implications (5 papers) and HIV/AIDS drug development and treatment (3 papers). Jerome C. Bressi is often cited by papers focused on Biochemical and Molecular Research (6 papers), Trypanosoma species research and implications (5 papers) and HIV/AIDS drug development and treatment (3 papers). Jerome C. Bressi collaborates with scholars based in United States, Belgium and Bulgaria. Jerome C. Bressi's co-authors include Michael H. Gelb, Wim G. J. Hol, Anthony R. Gangloff, Yiqin Wu, Marc Navre, Ron de Jong, Andy Jennings, Shawn M. O’Connell, R.J. Skene and Christophe L. M. J. Verlinde and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Jerome C. Bressi

10 papers receiving 565 citations

Peers

Jerome C. Bressi
Mark E. Zupec United States
Fred E. Cohen United States
T.L. Arakaki United States
Lianhu Wei Canada
M.D. Rackham United Kingdom
Shoukath M. Ali United States
Nandini S. Kishore United States
Corey L. Strickland United States
Nahoum G. Anthony United Kingdom
Mark E. Zupec United States
Jerome C. Bressi
Citations per year, relative to Jerome C. Bressi Jerome C. Bressi (= 1×) peers Mark E. Zupec

Countries citing papers authored by Jerome C. Bressi

Since Specialization
Citations

This map shows the geographic impact of Jerome C. Bressi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome C. Bressi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome C. Bressi more than expected).

Fields of papers citing papers by Jerome C. Bressi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome C. Bressi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome C. Bressi. The network helps show where Jerome C. Bressi may publish in the future.

Co-authorship network of co-authors of Jerome C. Bressi

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome C. Bressi. A scholar is included among the top collaborators of Jerome C. Bressi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome C. Bressi. Jerome C. Bressi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bressi, Jerome C., Ron de Jong, Yiqin Wu, et al.. (2010). Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 20(10). 3138–3141. 47 indexed citations
2.
Bressi, Jerome C., Andy Jennings, R.J. Skene, et al.. (2010). Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorganic & Medicinal Chemistry Letters. 20(10). 3142–3145. 213 indexed citations
3.
Verlinde, Christophe L. M. J., Jerome C. Bressi, Jungwoo Choe, et al.. (2002). Protein structure-based design of anti-protozoal drugs. Journal of the Brazilian Chemical Society. 13(6). 843–844. 9 indexed citations
4.
Seligson, Allen L., et al.. (2001). A new prodrug of paclitaxel: synthesis of Protaxel. Anti-Cancer Drugs. 12(4). 305–313. 29 indexed citations
5.
Suresh, Stephen, Jerome C. Bressi, Kevin J. Kennedy, et al.. (2001). Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors. Journal of Molecular Biology. 309(2). 423–435. 51 indexed citations
6.
Kennedy, Kevin J., Jerome C. Bressi, & Michael H. Gelb. (2001). A disubstituted NAD+ analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 11(2). 95–98. 27 indexed citations
7.
Bressi, Jerome C., Christophe L. M. J. Verlinde, Alex M. Aronov, et al.. (2001). Adenosine Analogues as Selective Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase of Trypanosomatidae via Structure-Based Drug Design. Journal of Medicinal Chemistry. 44(13). 2080–2093. 90 indexed citations
8.
Bressi, Jerome C., Jungwoo Choe, Frederick S. Buckner, et al.. (2000). Adenosine Analogues as Inhibitors of Trypanosoma brucei Phosphoglycerate Kinase:  Elucidation of a Novel Binding Mode for a 2-Amino-N6-Substituted Adenosine. Journal of Medicinal Chemistry. 43(22). 4135–4150. 59 indexed citations
9.
Bressi, Jerome C., et al.. (2000). Polymer-Assisted Solution-Phase Synthesis of 2‘-Amido-2‘-deoxyadenosine Derivatives Targeted at the NAD+-Binding Sites of Parasite Enzymes. Journal of Combinatorial Chemistry. 2(5). 537–544. 18 indexed citations
10.
Bernstein, B, David M. Williams, Jerome C. Bressi, et al.. (1998). A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma brucei. Journal of Molecular Biology. 279(5). 1137–1148. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026